cagrilintide and retatrutide reddit 10mg Retatrutide, an experimental weight-loss drug,

Food and Drug Administration Primary regulatory Apr 22, 2026 accessed Jul 16, 2026 FDA compounding-risk page whose withdrawn-nomination table includes GHK-Cu for injectable routes

While these claims sound promising (except for the one that makes it easier to tan), the 2023 FDA findings reveal that these peptides may come with significant safety risks

However, the trial is listed as canceled, which indicates the study sponsor or investigator recalled a submission of study results before quality control review took place

Consistent Administration Over Time Across multiple studies, BPC-157 is typically administered regularlydaily or multiple times per dayrather than timed around specific activities like exercise

Can you take BPC-157 every day

Public docket FDA-2025-N-6895: Open for written comments through July 22, 2026, the day before the meeting convenes